A Prospective Randomized Study Comparing the Effect of Different Kidney Protection Treatment Protocols on Acute Renal Injury After Extracorporeal Shockwave Lithotripsy
J Endourol · 2017 · Vol. 31 · Issue 1 · 57-65
Academy Summary
A Prospective Randomized Study Comparing the Effect of Different Kidney Protection Treatment Protocols on Acute Renal Injury After Extracorporeal Shockwave Lithotripsy examined a clinically important component of shock wave lithotripsy, with particular relevance to SWL Treatment Optimisation.
The investigators used a Prospective Randomized Controlled Trial in adults with solitary renal stones under 15 mm. This design strengthens comparison between the treatment strategies studied, although the conclusions still remain tied to the lithotripter, protocol and eligibility criteria used.
In 320 patients with solitary renal stones, different ramping and pause protocols were compared using imaging-detected renal hematoma and acute renal injury markers.
SWL outcome depends on both patient selection and treatment delivery.
The study contributes a focused piece of evidence to a treatment pathway that is inherently multifactorial. The result of one study should be integrated with stone factors, patient factors, lithotripter characteristics and operator technique.
Published in 2017, the study should still be interpreted according to its specific lithotripter, patient selection and outcome definitions rather than assumed to represent every modern SWL system.
For the Lithotripsy Academy database, the paper is most useful when interpreted as part of the complete treatment pathway rather than as an isolated numerical rule. Patient selection determines the opportunity for success, while targeting, coupling, shock-wave rate, energy strategy and operator technique determine how effectively that opportunity is converted into fragmentation and clearance.
Comments & Discussion0 comments
Discuss the publication's evidence, limitations and practical relevance. Please do not include identifiable patient information or individual medical advice.
No comments yet. Start the discussion.
Please log in to join the discussion.
